- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on PCO in Belgium
Total 13 results
-
Universitair Ziekenhuis BrusselUnknown
-
AZ Jan Palfijn GentOnze Lieve Vrouw HospitalCompletedInfertility | PCOSBelgium
-
University Hospital, AntwerpUniversitaire Ziekenhuizen KU Leuven; KU LeuvenUnknownPercutaneous Coronary Intervention (PCI) | Coronary Artery Disease (CAD); | Myocardial Infarction (MI) | Coronary Artery Bypass Grafting (CABG)Belgium
-
Rhythm Pharmaceuticals, Inc.CompletedPro-opiomelanocortin (POMC) Deficiency ObesityBelgium, United States, Canada, France, Germany, Spain, United Kingdom
-
Universitaire Ziekenhuizen KU LeuvenCompletedObesity | Metabolic Syndrome | PCOSBelgium
-
Cliniques universitaires Saint-Luc- Université...BioMérieuxCompleted
-
University Hospital of PatrasNot yet recruitingCoronary Artery Disease | ST Elevation Myocardial Infarction | Percutaneous Coronary Intervention | Coronary Catheterization | Distal Transradial Artery | Transradial Artery | Primary PCIBelgium, Greece, Switzerland
-
Insel Gruppe AG, University Hospital BernSahajanand Medical Technologies LimitedRecruitingAtrial Fibrillation (AF) | Oral Anticoagulation | Percutaneous Coronary Intervention (PCI) | P2Y12 InhibitorSpain, France, Switzerland, United Kingdom, Germany, Belgium, Italy, Netherlands, Poland
-
ECRI bvUniversity of Bern; European Cardiovascular Research Center; Terumo Medical Corporation and other collaboratorsCompletedCoronary Artery Disease | PCI | High Bleeding RiskNetherlands, France, United Kingdom, Australia, Singapore, Japan, Italy, Poland, Spain, Switzerland, Israel, Argentina, Austria, Bahrain, Bangladesh, Belgium, Bulgaria, Czechia, Denmark, Estonia, Germany, Hungary, India, Korea, Republic... and more
-
Ablynx, a Sanofi companyCompletedUnstable Angina | Non ST Segment Elevation Myocardial Infarction (NSTEMI) | Stable Angina (Associated With High Risk PCI)Poland, Belgium, Germany, Israel, Austria, Switzerland, Czechia
-
AstraZenecaRecruitingAdv Solid Malig - H&N SCC, ATM Pro / Def NSCLC, Gastric, Breast and Ovarian CancerSpain, United States, Belgium, United Kingdom, France, Hungary, Canada, Korea, Republic of, Australia
-
Novartis PharmaceuticalsActive, not recruitingLocally Advanced or Metastatic KRAS G12C-mutated NSCLC With a PD-L1 Expression <1% or a PD-L1 Expression ≥ 1% and an STK11 Co-mutationSpain, Italy, Austria, Netherlands, United Kingdom, Germany, Thailand, France, Belgium, China, Argentina, Greece, Turkey, Malaysia, Portugal, Hungary, Brazil, United States, India
-
Janssen Vaccines & Prevention B.V.CompletedParticipants With or Without Stable Co-morbidities Associated With Progression to Severe COVID-19United States, United Kingdom, Belgium, Spain, France, Germany, Philippines, Brazil, Colombia, South Africa